Report Detail
Global Radioisotopes in Medicine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4767329 |
- 29 October, 2026 |
- Global |
- 115 Pages |
- GIR |
- Chemical & Material
According to our (Global Info Research) latest study, the global Radioisotopes in Medicine market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person"s specific organs, or to treat them. Diagnostic procedures using radioisotopes are now routine. Radiotherapy can be used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. The attributes of naturally decaying atoms, known as radioisotopes, give rise to several applications across many aspects of modern day life. There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report is a detailed and comprehensive analysis for global Radioisotopes in Medicine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Radioisotopes in Medicine market size and forecasts, in consumption value ($ Million), sales quantity (K Curie), and average selling prices (US$/Curie), 2021-2032
Global Radioisotopes in Medicine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Curie), and average selling prices (US$/Curie), 2021-2032
Global Radioisotopes in Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Curie), and average selling prices (US$/Curie), 2021-2032
Global Radioisotopes in Medicine market shares of main players, shipments in revenue ($ Million), sales quantity (K Curie), and ASP (US$/Curie), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Radioisotopes in Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Radioisotopes in Medicine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NRG, IRE, ANSTO, NTP Radioisotopes, China National Nuclear Corporation, Rosatom, Nordion, Eckert & Ziegler Strahlen, Polatom, SHINE Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Radioisotopes in Medicine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Tc-99m
Cobalt-60
Iodine Radioisotopes
Others
Market segment by Application
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Major players covered
NRG
IRE
ANSTO
NTP Radioisotopes
China National Nuclear Corporation
Rosatom
Nordion
Eckert & Ziegler Strahlen
Polatom
SHINE Technologies
NorthStar Medical Radioisotopes
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radioisotopes in Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Radioisotopes in Medicine, with price, sales quantity, revenue, and global market share of Radioisotopes in Medicine from 2021 to 2026.
Chapter 3, the Radioisotopes in Medicine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radioisotopes in Medicine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Radioisotopes in Medicine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Radioisotopes in Medicine.
Chapter 14 and 15, to describe Radioisotopes in Medicine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Radioisotopes in Medicine Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Tc-99m
- 1.3.3 Cobalt-60
- 1.3.4 Iodine Radioisotopes
- 1.3.5 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Radioisotopes in Medicine Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Nuclear Therapy
- 1.4.3 Equipment Radioactive Source
- 1.4.4 Diagnosis
- 1.5 Global Radioisotopes in Medicine Market Size & Forecast
- 1.5.1 Global Radioisotopes in Medicine Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Radioisotopes in Medicine Sales Quantity (2021-2032)
- 1.5.3 Global Radioisotopes in Medicine Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 NRG
- 2.1.1 NRG Details
- 2.1.2 NRG Major Business
- 2.1.3 NRG Radioisotopes in Medicine Product and Services
- 2.1.4 NRG Radioisotopes in Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 NRG Recent Developments/Updates
- 2.2 IRE
- 2.2.1 IRE Details
- 2.2.2 IRE Major Business
- 2.2.3 IRE Radioisotopes in Medicine Product and Services
- 2.2.4 IRE Radioisotopes in Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 IRE Recent Developments/Updates
- 2.3 ANSTO
- 2.3.1 ANSTO Details
- 2.3.2 ANSTO Major Business
- 2.3.3 ANSTO Radioisotopes in Medicine Product and Services
- 2.3.4 ANSTO Radioisotopes in Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 ANSTO Recent Developments/Updates
- 2.4 NTP Radioisotopes
- 2.4.1 NTP Radioisotopes Details
- 2.4.2 NTP Radioisotopes Major Business
- 2.4.3 NTP Radioisotopes Radioisotopes in Medicine Product and Services
- 2.4.4 NTP Radioisotopes Radioisotopes in Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 NTP Radioisotopes Recent Developments/Updates
- 2.5 China National Nuclear Corporation
- 2.5.1 China National Nuclear Corporation Details
- 2.5.2 China National Nuclear Corporation Major Business
- 2.5.3 China National Nuclear Corporation Radioisotopes in Medicine Product and Services
- 2.5.4 China National Nuclear Corporation Radioisotopes in Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 China National Nuclear Corporation Recent Developments/Updates
- 2.6 Rosatom
- 2.6.1 Rosatom Details
- 2.6.2 Rosatom Major Business
- 2.6.3 Rosatom Radioisotopes in Medicine Product and Services
- 2.6.4 Rosatom Radioisotopes in Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Rosatom Recent Developments/Updates
- 2.7 Nordion
- 2.7.1 Nordion Details
- 2.7.2 Nordion Major Business
- 2.7.3 Nordion Radioisotopes in Medicine Product and Services
- 2.7.4 Nordion Radioisotopes in Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Nordion Recent Developments/Updates
- 2.8 Eckert & Ziegler Strahlen
- 2.8.1 Eckert & Ziegler Strahlen Details
- 2.8.2 Eckert & Ziegler Strahlen Major Business
- 2.8.3 Eckert & Ziegler Strahlen Radioisotopes in Medicine Product and Services
- 2.8.4 Eckert & Ziegler Strahlen Radioisotopes in Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Eckert & Ziegler Strahlen Recent Developments/Updates
- 2.9 Polatom
- 2.9.1 Polatom Details
- 2.9.2 Polatom Major Business
- 2.9.3 Polatom Radioisotopes in Medicine Product and Services
- 2.9.4 Polatom Radioisotopes in Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Polatom Recent Developments/Updates
- 2.10 SHINE Technologies
- 2.10.1 SHINE Technologies Details
- 2.10.2 SHINE Technologies Major Business
- 2.10.3 SHINE Technologies Radioisotopes in Medicine Product and Services
- 2.10.4 SHINE Technologies Radioisotopes in Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 SHINE Technologies Recent Developments/Updates
- 2.11 NorthStar Medical Radioisotopes
- 2.11.1 NorthStar Medical Radioisotopes Details
- 2.11.2 NorthStar Medical Radioisotopes Major Business
- 2.11.3 NorthStar Medical Radioisotopes Radioisotopes in Medicine Product and Services
- 2.11.4 NorthStar Medical Radioisotopes Radioisotopes in Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 NorthStar Medical Radioisotopes Recent Developments/Updates
3 Competitive Environment: Radioisotopes in Medicine by Manufacturer
- 3.1 Global Radioisotopes in Medicine Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Radioisotopes in Medicine Revenue by Manufacturer (2021-2026)
- 3.3 Global Radioisotopes in Medicine Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Radioisotopes in Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Radioisotopes in Medicine Manufacturer Market Share in 2025
- 3.4.3 Top 6 Radioisotopes in Medicine Manufacturer Market Share in 2025
- 3.5 Radioisotopes in Medicine Market: Overall Company Footprint Analysis
- 3.5.1 Radioisotopes in Medicine Market: Region Footprint
- 3.5.2 Radioisotopes in Medicine Market: Company Product Type Footprint
- 3.5.3 Radioisotopes in Medicine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Radioisotopes in Medicine Market Size by Region
- 4.1.1 Global Radioisotopes in Medicine Sales Quantity by Region (2021-2032)
- 4.1.2 Global Radioisotopes in Medicine Consumption Value by Region (2021-2032)
- 4.1.3 Global Radioisotopes in Medicine Average Price by Region (2021-2032)
- 4.2 North America Radioisotopes in Medicine Consumption Value (2021-2032)
- 4.3 Europe Radioisotopes in Medicine Consumption Value (2021-2032)
- 4.4 Asia-Pacific Radioisotopes in Medicine Consumption Value (2021-2032)
- 4.5 South America Radioisotopes in Medicine Consumption Value (2021-2032)
- 4.6 Middle East & Africa Radioisotopes in Medicine Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Radioisotopes in Medicine Sales Quantity by Type (2021-2032)
- 5.2 Global Radioisotopes in Medicine Consumption Value by Type (2021-2032)
- 5.3 Global Radioisotopes in Medicine Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Radioisotopes in Medicine Sales Quantity by Application (2021-2032)
- 6.2 Global Radioisotopes in Medicine Consumption Value by Application (2021-2032)
- 6.3 Global Radioisotopes in Medicine Average Price by Application (2021-2032)
7 North America
- 7.1 North America Radioisotopes in Medicine Sales Quantity by Type (2021-2032)
- 7.2 North America Radioisotopes in Medicine Sales Quantity by Application (2021-2032)
- 7.3 North America Radioisotopes in Medicine Market Size by Country
- 7.3.1 North America Radioisotopes in Medicine Sales Quantity by Country (2021-2032)
- 7.3.2 North America Radioisotopes in Medicine Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Radioisotopes in Medicine Sales Quantity by Type (2021-2032)
- 8.2 Europe Radioisotopes in Medicine Sales Quantity by Application (2021-2032)
- 8.3 Europe Radioisotopes in Medicine Market Size by Country
- 8.3.1 Europe Radioisotopes in Medicine Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Radioisotopes in Medicine Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Radioisotopes in Medicine Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Radioisotopes in Medicine Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Radioisotopes in Medicine Market Size by Region
- 9.3.1 Asia-Pacific Radioisotopes in Medicine Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Radioisotopes in Medicine Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Radioisotopes in Medicine Sales Quantity by Type (2021-2032)
- 10.2 South America Radioisotopes in Medicine Sales Quantity by Application (2021-2032)
- 10.3 South America Radioisotopes in Medicine Market Size by Country
- 10.3.1 South America Radioisotopes in Medicine Sales Quantity by Country (2021-2032)
- 10.3.2 South America Radioisotopes in Medicine Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Radioisotopes in Medicine Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Radioisotopes in Medicine Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Radioisotopes in Medicine Market Size by Country
- 11.3.1 Middle East & Africa Radioisotopes in Medicine Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Radioisotopes in Medicine Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Radioisotopes in Medicine Market Drivers
- 12.2 Radioisotopes in Medicine Market Restraints
- 12.3 Radioisotopes in Medicine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Radioisotopes in Medicine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Radioisotopes in Medicine
- 13.3 Radioisotopes in Medicine Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Radioisotopes in Medicine Typical Distributors
- 14.3 Radioisotopes in Medicine Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Radioisotopes in Medicine. Industry analysis & Market Report on Radioisotopes in Medicine is a syndicated market report, published as Global Radioisotopes in Medicine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Radioisotopes in Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
